• Title/Summary/Keyword: 감마지티피

Search Result 3, Processing Time 0.02 seconds

A Study on the Estimation Method of Hemoglobin Based on Linear and Multiple Regression Analysis Using Health Examination Big Data (건강검진 빅데이터를 이용한 선형 및 다중회귀분석 기반 헤모글로빈 추정 방법에 관한 연구)

  • Hong, Sang-Hoon;Hong, Kwang-Seok
    • Proceedings of the Korea Information Processing Society Conference
    • /
    • 2021.05a
    • /
    • pp.553-555
    • /
    • 2021
  • 빈혈의 유병률은 매년 증가하고 있으나 이를 가벼운 질병으로 인식해 치료 시기를 놓치는 환자들이 존재한다. 빈혈의 발생원인으로 혈액 내 헤모글로빈 및 헤모글로빈 내 철 부족이 있으며, 헤모글로빈 측정기술의 경우 채혈 이외에 사람의 신체 및 건강 정보를 적용한 사례는 찾아보기 어렵다. 본 논문에서는 신체(키, 몸무게 및 허리둘레) 및 건강 정보(혈청지오티, 이완기 혈압 및 감마지티피 등)가 포함된 건강검진 빅데이터를 이용하여 단일 특징에 대해 선형회귀분석을 수행하고, 다중 특징에 대해 다중회귀분석을 수행하여 회귀분석 식을 산출, 산출된 회귀분석 식을 통해 헤모글로빈을 추정하여 실제 헤모글로빈값과 오차율을 계산하고 비교한다. 실험 결과, 선형회귀분석 식을 통해 헤모글로빈을 추정하였을 때 평균 8.124%의 오차율이 계산되었으며, 다중회귀분석의 경우 선형회귀분석보다 낮은 6.767%의 오차율이 계산되었다.

Evaluation of convergence Elasticity of Liver Fibroscan used measurement with Ultrasonography (초음파를 이용한 간 섬유화 스캔 검사의 융합 탄성도 측정 평가)

  • Kim, Min-Jeong;Han, Man-Seok;Jang, Jae-Uk
    • Journal of the Korea Convergence Society
    • /
    • v.8 no.5
    • /
    • pp.79-85
    • /
    • 2017
  • The purpose of this research was to evaluate the clinical and the instrument of convergence utility of transient elastography (FibroScan(R):electromagnetic wave) in diagnosing and treating liver ailments through a comparison and an analysis between liver function blood test and transient elastography (FibroScan(R)) in patients with chronic hepatitis B virus infection. Of all the patients with chronic hepatitis B virus infection who visited clinic B in Daejeon City between July 1, 2015, and February 28, 2016, 75 who underwent a FibroScan(R) test were selected for this study. Their laboratory and liver function test results were compared for a correlation analysis before constructing an ROC (Receiver Operation Characteristic) curve. Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels were 0.572 and 0.502, respectively, and showed highest correlation with fibrosis score, with statistical significance (p<0.000). Gamma glutamyltranspeptidase, total bilirubin, and alkaline phosphatase levels also showed relatively significant correlations in this order of sequence, while -fetoprotein and total protein levels did not show any statistically significant values. Albumin (-0.449) and platelet levels (-0.373) showed negative correlations with each other and no correlation with fibrosis score (p < 0.000). As liver fibrosis worsened, the accuracy of the ROC curve increased. At the F4 stage, which is the cirrhotic stage, the largest area under the curve was observed. FibroScan(R) showed significant correlation with the ALT (serum glutamic pyruvic transaminase) and AST (serum glutamic oxaloacetic transaminase) levels in the liver function test, which is a routine test for patients with chronic liver ailments. This implies that fibrosis correlates with liver inflammation severity.

Serum Gamma-glutamyltransferase Levels and the Risks of Impaired Fasting Glucose in Healthy Men: A 2-year Follow-up (건강한 남성에서 혈중 감마지티피 수준과 공복혈당장애 (IFG)의 발생 위험도: 2년 추적 연구)

  • Shin, Joo-Youn;Lim, Jong-Han;Koh, Dai-Ha;Kwon, Keun-Sang;Kim, Yong-Kyu;Kim, Hwan-Chul;Lee, Yeui-Cheol;Lee, Ju-Hyoung;Nam, Moon-Suk;Hong, Sung-Bin;Park, Shin-Goo
    • Journal of Preventive Medicine and Public Health
    • /
    • v.39 no.4
    • /
    • pp.353-358
    • /
    • 2006
  • Objectives: An increase in the serum gamma-glutamyltransferase (GGT) concentration has been regarded as a marker of alcohol drinking or liver disease. Some reports, however, have suggested that the serum GGT may be a sensitive and early biomarker for the development of prediabetes and diabetes. In this study we investigated whether serum GGT is a reliable predictor of the incident impaired fasting glucose (IFG), including diabetes. Methods: We performed a prospective study for two years (2002-2004). We analyzed the periodic health examination data from a total of 4,711 men. The examinations were done in the years 2002 and 2004. The analyzed data included a self-questionnaire, a physical examination and the laboratory results. Both IFG and diabetes were defined as a serum fasting glucose concentration of more than 100 mg/dL and 126 mg/dL, respectively. Results: A total of 738 cases (15.7%) of incident IFG and 13 cases (0.3%) of diabetes occurred. The mean serum GGT concentrations were quite different between the normal (38.0 IU) and incident IFG groups (50.3 IU), and the incident diabetes group (66.0 IU) (p<0.001). After multivariable adjustment, the relative risks for incident IFG or diabetes across the baseline GGT categories (<10th, 10th-20th, 30th-40th, 50th-60th, 70th-80th and >90th percentile) were 1.0, 1.172 (0.769-1.785), 1.107 (0.725-1.689), 1.444 (0.934-2.232), 2.061 (1.401-3.031) and 2.545 (1.784-3.631) (p-value for trend: <0.001). The risks significantly increased with increasing levels of GGT for 2 years; when comparing the increased groups (<10%, 10-20%, >20%) versus the decreased over 20% group of GGT, the risks for IFG or diabetes were 1.334 (1.002-1.776), 1.613 (1.183-2.199) and 1.399 (1.092-1.794). Conclusions: Our findings suggest that serum GGT concentrations within its normal range may be an early predictor of the development of IFG and diabetes. As serum GGT is a relatively inexpensive test and a reliable marker, it might have important implications in public health promotion.